8
Oct
2024

Cayman Pharma s.r.o

Exhibitor at CPHI Milan 2024 stand 3B89, API
About Us

Cayman Pharma is the world’s most reliable source of prostaglandin Active Pharmaceutical Ingredients (APIs) using its own patented route to manufacture APIs for erectile dysfunction, ophthalmic, veterinary, vascular, and psychedelic applications. Cayman Pharma has an excellent track record and an outstanding record of regulatory compliance. Together with Cayman Chemical Company, Cayman Pharma represents the accumulation of almost 60 years of experience with prostaglandin synthesis.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CZ
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 3B89, API

Products Featured at CPHI Milan 2024

  • CGMP (+)-Cloprostenol (sodium salt)

    Product CGMP (+)-Cloprostenol (sodium salt)

    (+)-Cloprostenol is the active enantiomer of Cloprostenol. Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. The ASMF for (+)-Cloprostenol (sodium salt) is on file in several EU member states.
  • CGMP Alprostadil

    Product CGMP Alprostadil

    Alprostadil is a vasodilator, and finds clinical use in treating erectile dysfunction, in improving blood flow in peripheral vascular disease, and in maintaining coronary circulation in neonates with vascular anomalies. The DMF for Alprostadil is on file with the US FDA, Canada, India, in many EU member st...
  • CGMP Bimatoprost

    Product CGMP Bimatoprost

    Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF is on file with the US FDA, Canada, and in several EU member states.
  • CGMP Epoprostenol (sodium salt)

    Product CGMP Epoprostenol (sodium salt)

    Epoprostenol is a potent vasodilator and antiplatelet substance with a very short physiologic half-life. It is used for the treatment of pulmonary hypertension. The DMF for Epoprostenol Sodium Salt is on file with the US FDA, Canada, Japan, Australia, and several EU member states.
  • CGMP (±)-Cloprostenol (sodium salt) 

    Product CGMP (±)-Cloprostenol (sodium salt) 

    Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. (±)-Cloprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material, which conforms to the USP and BVP Monogr...